Tuberc Respir Dis > Volume 54(6); 2003 > Article
Tuberculosis and Respiratory Diseases 2003;54(6):610-620.
DOI: https://doi.org/10.4046/trd.2003.54.6.610    Published online June 1, 2003.
Loss of FHIT Expression in Non-Small Cell Lung Cancer: The Clinical Significance and Effects on Apoptosis and Cell Proliferation Cycle.
Hak Ryul Kim, Sei Hoon Yang, Eun Taik Jeong
Department of Internal Medicine, College of Medicine, Wonkwang University, Iksan, Jeonbuk, Korea. jetpul@wonkwang.ac.kr
Abstract
BACKGROUND
3p deletion has been shown to be the most frequently occurring change in lung cancers, suggesting the presence of a tumor suppressor gene in this region. Recent attention has focused on a candidate 3p14.2 tumor suppressor gene, FHIT. Therefore, the association of the expression of FHIT, with apoptosis, cell proliferation cycle and the clinicopathological features, including survival, were investigated. MATERIALS AND METHODS: 83 patients with non-small cell lung cancer, who underwent curative operation, between Jan. 1996 and Aug. 2000, at the Wonkwang university hospital, were analyzed. The expression of the FHITwas identified by immunohistochemical staining, and rate of apoptosis and cell RESULTS: 43% (36/83) of patients exhibited no FHIT expression. The rates of FHIT loss were 52% (28/54), 22% (5/23), 50% (3/6); 30% (11/37), 48% (16/33), 69% (9/13); 54% (30/56) and 22% (6/27), in squamous cell cancers, adenocarcinomas, large cell cancers, TNM stages I, II and III, smokers and non-smokers, respectively. All the differences in FHIT loss rates, according to the histopathology, TNM stages and smoking habits, were statistically significant. The median survival time and 2-year survival rate of the FHIT(-) group were 24 months and 44%, and those of the FHIT(+) group were 25 months and 51% (p>0.05), respectively. The apoptotic rate of the FHIT(-) and FHIT(+) groups were 50.72 (+/- 13.93) and 59.38 (+/-14.33)%, respectively (p=0.01). The S- and G1-phase fractions of the FHIT(-) and FHIT(+) groups were 13.93 (+/-7.35) and 51.50(+/-23.15)% and 15.65(+/-6.59) and 54.16 (+/-20.25)%, respectively (p>0.05). CONCLUSION: The loss of FHIT expression was increased to a greater extent with advancing TNM stage, smoking habits and squamous cell cancer compared to the adenocarcinomas. However, no survival differences were found according to the expression of FHIT. The apoptotic rate of the FHIT(+) group was greater than in the FHIT(-) group, but differences in the S- and G1-phase fractions, according to the expression of the FHIT, were not found.
Key Words: Lung cancer, FHIT, Survival, Apoptosis, Cell cycle


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next